LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 49 filers reported holding LUMOS PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $748 | -2.0% | 226,714 | -1.9% | 0.00% | 0.0% |
| Q2 2023 | $763 | +0.3% | 231,159 | +0.5% | 0.00% | 0.0% |
| Q1 2023 | $761 | -9.6% | 229,914 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $842 | -100.0% | 233,114 | -6.9% | 0.00% | -66.7% |
| Q3 2022 | $2,217,000 | +6.6% | 250,513 | -7.3% | 0.00% | +50.0% |
| Q2 2022 | $2,080,000 | -18.6% | 270,112 | -0.6% | 0.00% | -33.3% |
| Q1 2022 | $2,554,000 | +33.0% | 271,712 | -1.9% | 0.00% | +50.0% |
| Q4 2021 | $1,920,000 | -29.5% | 277,112 | -3.2% | 0.00% | -50.0% |
| Q3 2021 | $2,724,000 | -10.9% | 286,412 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $3,058,000 | -21.4% | 305,757 | -8.0% | 0.00% | -20.0% |
| Q1 2021 | $3,889,000 | -64.7% | 332,419 | +7.6% | 0.01% | -58.3% |
| Q4 2020 | $11,028,000 | +160.7% | 308,812 | +0.9% | 0.01% | +200.0% |
| Q3 2020 | $4,230,000 | -17.0% | 306,112 | -1.0% | 0.00% | 0.0% |
| Q2 2020 | $5,099,000 | +91.6% | 309,191 | -1.2% | 0.00% | +33.3% |
| Q1 2020 | $2,661,000 | – | 313,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 125,242 | $413,299 | 0.24% |
| Lion Point Capital, LP | 90,794 | $299,620 | 0.13% |
| Greenwich Wealth Management LLC | 76,341 | $252 | 0.03% |
| Wealth Advisors of Iowa, LLC | 11,699 | $38,606 | 0.03% |
| Marquette Asset Management, LLC | 25,760 | $85,008 | 0.02% |
| Key FInancial Inc | 10,927 | $36,059 | 0.01% |
| Paladin Advisory Group, LLC | 4,387 | $14,477 | 0.01% |
| Blackstone Inc. | 468,145 | $1,544,879 | 0.01% |
| Leucadia National | 120,651 | $398,148 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $157,222 | 0.00% |